Sie sind auf Seite 1von 2

Explore New Ways to Uproot Diabetes from Monitoring to Management

As reported by the World Health Organization (WHO), on an average 1 out of every 13 people are
diagnosed globally with Diabetes each year and also projects that diabetes will be the 7th leading
cause of death in 2030. Number of people suffering from Diabetes disorders continues to rise each
year. Around 60% of the populations effected with Diabetes diseases are uncaring of the situation.
Diabetes has become one of the most threatening diseases in the EU. Despite of tremendous research
by the medical industry, a permanent solution for it is yet to be found. At this outset, Conference
series LLC’s Diabetes conferences needs attention of global scientific community.

The diabetes drugs market, valued as a USD 30.95 billion market in 2016, is expected to grow at an
exponential rate and become a USD 44.53 billion market by 2021, at a CAGR of about 7.5%. The
largest drug class in the market in 2016 was human insulin and analogues. This drug class held 55%
share of the global diabetes drugs market in 2016. Januvia (sitagliptin), the major candidate in
Merck’s diabetes portfolio, accounted for 64.3% of the company’s revenue from diabetes drugs in
2015. Growing investment in R&D by companies to cater a wide range of products is expected to
create immense growth opportunities for industry participants. Need for action is rising, as many new
cases turn up each year

Diabetes Meeting 2018 offers a unique opportunity for investigators across the globe to meet,
network, and perceive new scientific innovations. This year’s annual congress reflects the innovative
progress in Diabetes research. Our primary objective is to provide unique opportunity to network with
a wide range of professionals in the field of diabetes. It will feature the latest developments in
research, diagnosis and prevention of diabetes, new insulin analogues, new technologies and devices
for diabetic prevention, obesity and many more.

Scientists around the world are conducting diabetes research across a phenomenal variety of fields.
Diabetes researchers are making great progress in understanding the basic science of diabetes. Many
findings have already proceeded on the road to new treatments. For every new strategy that succeeds,
the benefit to millions of people will be huge. With diabetes increasingly affecting every country in
the world, diabetes researchers from across the planet are working towards thousands of different
research goals.

Through our series of diabetes conferences we provide an international forum to scientists, young
researchers, physicians, health care professionals and encourage discussions among diabetes
researchers to enhance the latest scholarly research, and disseminate research findings of particular
interest.

Conference Series focuses on themes suitable to meet the needs of diabetes professionals of all levels
by including endocrinology and Metabolic Syndrome to meet the individual as well as mass
healthcare needs to improve the health of millions of individuals in any setting. World renowned
scientists, Noble laureates and scholars in their respective fields grace our events as keynote speakers,
panel experts, and organizing committee members.

Conference Series has a long-standing tradition of honouring and uplifting early career researchers
of diabetes and healthcare profession through Student Ambassador Program and Young Researcher
Forum (YRF)

Conference Series is pioneer in organizing Academic, Scientific and Business conferences, meetings,
symposiums and exhibitions on a cross section of fields like Medical, Pharmaceutical, Engineering,
Science and Technology to promote scientific research. Every year we host more than 3000+
International Conferences in USA, Europe, Middle East and Asia with the generous support and
cooperation from our 50000+ Editorial Board Members, 1000+ Scientific Societies. All the
conference proceedings are published as special issues in our 1000+ Open Access International
Journals with the DOI provided by CROSSREF.

For more details visit: https://diabetesmeeting.conferenceseries.com/


Contact
Catherine Dean
Conference Manager| Diabetes Meeting 2018
P: +1 702-508-5201
Email: diabetesmeeting@endocrineconfereces.com

Das könnte Ihnen auch gefallen